Clinical Trial Update: Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a chemoprevention therapy for individuals at high risk of developing multiple myeloma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED